ストックスクリーナーアプリを入手
2.70
6.72%
0.17
Cvrx Inc (CVRX) 最新ニュース
CVRX Oct 2026 2.500 call (CVRX261016C00002500) Stock Historical Prices & DataYahoo Finance - Yahoo! Finance Canada
CVRX Oct 2026 10.000 call (CVRX261016C00010000) stock historical prices and data - Yahoo Finance UK
CVRX Oct 2026 5.000 put (CVRX261016P00005000) Stock Price, News, Quote & History - Yahoo! Finance Canada
CVRX Oct 2026 10.000 call (CVRX261016C00010000) interactive stock chart - Yahoo Finance UK
CVRx stock falls 6.99 percent as CFO transition takes shape - AD HOC NEWS
CVRX Oct 2026 2.500 put (CVRX261016P00002500) Interactive Stock ChartYahoo Finance - Yahoo! Finance Canada
HAGENS BERMAN, NATIONAL SECURITIES LAW FIRM, Encourages - GlobeNewswire
CVRx names John Landry as CFO - MedTech Dive
CVRx Inc. (CVRX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
CVRx taps new CFO from Nyxoah - MassDevice
CVRx, Inc. (CVRX) stock price, news, quote and history - Yahoo Finance UK
Lake Street Downgrades CVRx Inc(CVRX.US) to Hold Rating, Cuts Target Price to $3.5 - Moomoo
Canaccord reiterates CVRx stock Buy rating after CFO appointment By Investing.com - Investing.com South Africa
Canaccord reiterates CVRx stock Buy rating after CFO appointment - Investing.com
CVRx Faces Fresh Pressure as Activist Pushes a Sale - finimize.com
CVRx appoints John Landry as chief financial officer By Investing.com - Investing.com South Africa
CVRx Appoints John Landry as Chief Financial Officer - Minichart
CVRX Q2 2026 Earnings: Narrower-Than-Expected Loss Met With a 2.3% PullbackEarnings Quality Analysis - siam.in
CVRx appoints John Landry as chief financial officer - Investing.com
CVRx Names New Chief Financial Officer - marketscreener.com
Cvrx Appoints John Landry As Chief Financial Officer - TradingView
CVRx, Inc. Appoints John Landry as Chief Financial Officer, Effective October 12, 2026 - marketscreener.com
CVRx stock holds steady as investors eye latest revenue growth - AD HOC NEWS
CVRx stock dips as Cantor slashes price target after guidance update - AD HOC NEWS
Investigation launched into CVRx over DOJ probe, sales issues, and sudden CRO firing. - Pluang
HAGENS BERMAN, NATIONAL SECURITIES LAW FIRM, Encourages CVRx Inc. (CVRX) Investors with Substantial Losses to Contact Firm: Investigating Potential Securities Fraud Following 59% Stock Drop - PR Newswire
CVRX Q2 2026 Earnings: Narrower-Than-Expected Loss, But Shares Slip 1.38%Buyback Announcement Report - siam.in
CVRX stock edges higher as investors watch neuromodulation growth - ad-hoc-news.de
CVRX stock benefits as Barostim heart failure therapy gains new Medicare Advantage coverage - ad-hoc-news.de
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of CVRx, Inc.CVRX - PR Newswire
CVRx Secures Devoted Health Coverage for Barostim Therapy - Prime Publishers, Inc.
Bronstein, Gewirtz & Grossman, LLC Is Investigating CVRx, Inc. (CVRX) And Encourages Shareholders to Connect - accessnewswire.com
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims - PR Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against CVRx, Inc. (CVRX) and Encourages Shareholders to Learn More About the Investigation - accessnewswire.com
Down 31.7% in 4 Weeks, Here's Why You Should You Buy the Dip in CVRx (CVRX) - qz.com
CVRx has an activist investor urging it to get acquired - MassDevice
CVRx Responds to Letter from Pointillist Family Office - marketscreener.com
3 Penny Stocks With At Least $70M Market Cap - simplywall.st
CVRx earns new Medicare Advantage coverage policy for Barostim - MassDevice
CVRx Inc. Faces Securities Law Investigation Over Revenue Guidance Cut and DOJ Demand - kalkine.ca
Investor holding 5.5% of CVRx urges board to pursue sale By Investing.com - Investing.com Nigeria
CVRx Announces Devoted Health Medicare Advantage Coverage Policy for Barostim Therapy - The Manila Times
Jorey Chernett, Owner of More Than 5.5% of Ou - Moomoo
Bronstein, Gewirtz & Grossman, LLC Is Investigating CVRx, Inc. (CVRX) And Encourages Investors to Connect - Stockhouse
Bronstein, Gewirtz & Grossman, LLC Encourages CVRx, Inc. (CVRX) Stockholders to Inquire about Securities Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against CVRx, Inc. (CVRX) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Aga - The National Law Review
CVRx (CVRX) Could Find a Support Soon, Here's Why You Should Buy the Stock Now - Eastern Progress
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation into Allegations Against CVRx, Inc. (CVRX) And Encourages Investors to Reach Out - ACCESS Newswire
Bronstein, Gewirtz & Grossman, LLC Initiates an Investigation int - The National Law Review
Law firm investigates CVRx for possible securit... - Pluang
Cantor Fitzgerald Maintains CVRx Inc(CVRX.US) With Buy Rating, Cuts Target Price to $5 - Moomoo
Cantor cuts CVRx stock price target on sales execution challenges By Investing.com - Investing.com South Africa
CVRX Q2 2026 Earnings: Modest EPS Beat Offset by 10.71% Share SlidePositive Surprise Momentum - vinanet.vn
Cantor cuts CVRx stock price target on sales execution challenges - Investing.com
Cantor Fitzgerald Issues Pessimistic Forecast for CVRx (NASDAQ:CVRX) Stock Price - MarketBeat
Johnson & Johnson Invests $20.69 Billion in CVRx, Inc. $CVRX - MarketBeat
1.51%
0.97%
大文字化:
|
ボリューム (24 時間):